Yu-Chien Chou

1.4k citations
5 papers · 1.1k indexed · 1 hit paper · h-index 5
Topics
Estrogen and related hormone effects (3 papers)HER2/EGFR in Cancer Research (1 paper)RNA modifications and cancer (1 paper)
Partner nations
United StatesJapan

In The Last Decade

Yu-Chien Chou

5 papers receiving 1.1k citations

Hit Papers

Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, S...201120262016202120112505007501000

Peers

Yu-Chien Chou
Comparison fields: 5 of 74
  • Oncology 481
  • Molecular Biology 445
  • Pulmonary and Respiratory Medicine 418
  • Hepatology 241
  • Cancer Research 201
Replace Yongchang Shi with:
Yongchang Shi United States
Jessica Orf United States
Kotaro Kodama Japan
Lone H. Ottesen United States
Laura W. Goff United States
Jingrong Jean Cui United States
Ellen Hollywood United States
Osamu Tohyama Japan
Paula Kaplan‐Lefko United States
Melissa Dumble United States
Yu-Chien Chou relative to Yongchang Shi United States Yongchang Shi's profile →
Citations per field
00.5×1.5×
Yongchang Shi · 1×
Citations per year

Countries citing papers authored by Yu-Chien Chou

Since Specialization
Citations

This map shows the geographic impact of Yu-Chien Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Chien Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Chien Chou more than expected).

Fields of papers citing papers by Yu-Chien Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Chien Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Chien Chou. The network helps show where Yu-Chien Chou may publish in the future.

Co-authorship network of co-authors of Yu-Chien Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Chien Chou. A scholar is included among the top collaborators of Yu-Chien Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Chien Chou. Yu-Chien Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growthbreakdown →
1036
2 19
3 37
4 20
5 20

About Yu-Chien Chou

Yu-Chien Chou is a scholar working on Physiology, Hepatology and Genetics, having authored 5 papers that have together received 1.1k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (3 papers), HER2/EGFR in Cancer Research (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Hepatology (241 citations), Oncology (481 citations) and Cancer Research (201 citations). Yu-Chien Chou has collaborated with scholars based in United States and Japan. Frequent co-authors include Fawn Qian, Jason Chen, Justin Lesch, Alexander Laird, Yongchang Shi, F. Michael Yakes, Toshihiro Yamaguchi, Felix Chu, Jessica Orf and Lillian Lee. Their work appears in journals such as Cancer Research, Carcinogenesis and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026